19:35

הוריו של סמ״ר איתי חן לוחם נואמים במוצ״ש בקפלן

13:38

מחאת קפלן - הדוברת ענת גילור - קיבוץ חולית, מוצ״ש 6 אפריל 2024

01:05

Journal of IVF-Worldwide (JIVFww)

10:02

מכתב הדודה ליריב לוין - קורא נעם לניר בבוקר מחאת האחים והאחיות לנשק מול ביתו של שר המשפטים

07:07

שמיניות באויר

01:39

Spectacled cobra snake rescue operation from artificial farm pond

27:04

Experimental Methods to Preserve and Restore Male Fertility | Kyle ORWIG

29:38

The Future of ART: Should We, and Can We, Avoid the Mad Hatter’s Tea Party

02:25

נוטריה השוכנת בנחל האסי של קיבוץ ניר דוד

24:58

The Role of Sperm in Facilitation of Fertilization | Gerald SCHATTEN

29:32

PCOS 2018 Guideline Explained | Michael COSTELLO

33:03

Advances in Preimplantation Genetic Diagnosis | Sijia LU

31:25

From IVF to Germline Gene Editing: Ethical Challenges | Vardit RAVITSKY

22:19

Gamete & Embryo Freezing Vs Ovarian Tissue Freezing | Sherman SILBER

45:58

How Can We Improve Outcome (Embryology) | Simon FISHEL

35:05

Have We Reached the Limit in Human IVF | Pasquale PATRIZIO

17:09

Vasorin: A Newly Identified Ovarian Regulator | Nava DEKEL

25:16

Nuclear Transfer and Human Egg Reconstruction: Clinical Update | John ZHANG

36:32

The Autoimmune Bases of Infertility | Dongzi YANG

36:02

The Aged Ovary | Sherman SILBER

41:47

The Future of IVF – Can We Be Better | Nobert GLEICHER

18:53

3D Ovary | Monica LARONDA

01:47

What are the swallows doing over the fish pond?

15:34

MRD evaluation: Practical aspects | Hervé Avet- Loiseau

40:13

Monoclonal antibodies & Is there an optimal sequencing of therapy?

24:07

Debate - Autologous transplant frontline for the elderly | Mohty vs Blade

14:29

Debate - MRD-driven therapy | Jesus San Miguel

16:25

Debate - Continuous therapy as a standard of care | Facon

13:29

Debate - Should we treat smoldering myeloma? Mateos

35:40

Myeloma in 2025 | Kenneth Anderson

11:02

Debate - Should we treat smoldering myeloma? Con: Leleu

28:43

Do affordable & effective strategies in young patients exist? Rajkumar

16:11

Extramedullary disease | Saad Usmani

16:21

Chemotherapy-based stem cell mobilization | Mohty

19:27

New drugs in the pipeline | Maria Victoria Mateos

19:30

IMiDs and proteasome inhibitors | Meral Beksac

16:53

Role for salvage autologous transplantation | Arnon Nagler

24:00

Latest results of immunotherapy | Sagar Lonial

13:10

Optimal management of myeloma in countries w/ limited resources | Kumar

11:17

Practical considerations when using anti-CD38 antibodies | Plesner

16:11

Allogeneic stem cell transplantation for high-risk cytogenetics frontline | Schjesvold

20:10

Prevention of Progression in Multiple Myeloma | Irene Ghobrial

18:55

Plasma cell leukemia | Francesca Gay

28:47

Debate - Alkylating agents as part of frontline therapy in the elderly | Yong vs Facon

11:50

The case for 2nd generation proteasome inhibitors | Lonial

16:16

Practical considerations for the management of frail patients | Hulin

17:23

Ultra-high risk cytogenetics | Niels van de Donk

17:01

How to define smoldering myeloma? Rajkumar

16:22

The case for monoclonal antibodies | Usmani

16:04

Novel imaging techniques | Elena Zamagni

14:09

Criteria for disease assessment | Joan Blade

22:44

Role of consolidation including double autologous transplant | Sonneveld

21:31

Advances in Waldenstrom macroglobulinemia | Treon

16:13

Quality of life considerations in myeloma | Rachid Baz

21:07

Bone disease | Evangelos Terpos

16:10

Drug combinations: the role of signaling pathways | Marc Raab

19:57

Clonality | Nikhil Munshi

22:13

Bases for immunotherapy | Paola Neri

10:20

"Cytogenetics and genomics: an update" by Hervé Avet- Loisea

10:20

Cytogenetics and genomics: an update | Hervé Avet Loiseau